Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SAMSCA
- Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH
- Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction
- Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
- Tolvaptan for Advanced or Refractory Heart Failure
- Efficacy of Tolvaptan on ADPKD Patients
- Regional Tolvaptan Registry
- AiDing Diuresis wIth Tolvaptan (ADD-IT)
- Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
- Tolvaptan for Patients With Acute Neurological Injuries
- Effect of the Aquaretic Tolvaptan on Nitric Oxide System
- Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders
- A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
- Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
- Aquaresis Utility for Hyponatremic Acute Heart Failure Study
- Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study
- V2 Receptor Effects on Fluid Regulation and Performance
- Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)
- An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia
- Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
- A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
- Effects of Tolvaptan in Healthy Adults
- Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)
- Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
- Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
- Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
- Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)
- Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
- Effect of Tolvaptan on Cognitive Function in Cirrhosis
- Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites
- Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis
- Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
- Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
- Pilot Study of Using Copeptin to Predict Response to Tolvaptan
- Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact
- Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice
- Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
- Tolvaptan in Hyponatremic Cancer Patients
Clinical trials list
click for details